Coexpression cluster:C94

Full id: C94_smallcell_adrenal_lung_nonsmall_small_somatostatinoma_teratocarcinoma

Phase1 CAGE Peaks

Hg19::chr10:126027036..126027041,-	p@chr10:126027036..126027041 -
Hg19::chr10:5407022..5407032,+	p4@UCN3
Hg19::chr10:77056134..77056153,+	p1@ZNF503-AS1
Hg19::chr10:77056181..77056190,+	p2@ZNF503-AS1
Hg19::chr11:115158193..115158232,-	p15@CADM1
Hg19::chr11:14992712..14992724,-	p2@CALCA
Hg19::chr11:1643592..1643602,+	p@chr11:1643592..1643602 +
Hg19::chr11:4718911..4718938,-	p2@OR51E2
Hg19::chr11:4718944..4718953,-	p4@OR51E2
Hg19::chr11:4719014..4719028,-	p3@OR51E2
Hg19::chr11:4719072..4719089,-	p1@OR51E2
Hg19::chr11:60467048..60467063,+	p4@MS4A8B
Hg19::chr12:103353319..103353328,+	p@chr12:103353319..103353328 +
Hg19::chr12:127992016..127992052,+	p@chr12:127992016..127992052 +
Hg19::chr12:128077388..128077416,+	p@chr12:128077388..128077416 +
Hg19::chr12:15784419..15784458,-	p18@EPS8
Hg19::chr12:22852866..22852887,+	p1@ENST00000536744
Hg19::chr12:23791058..23791099,+	p@chr12:23791058..23791099 +
Hg19::chr12:50284871..50284904,-	p@chr12:50284871..50284904 -
Hg19::chr12:86268065..86268080,+	p1@NTS
Hg19::chr12:86272210..86272219,+	p@chr12:86272210..86272219 +
Hg19::chr12:86272273..86272280,+	p@chr12:86272273..86272280 +
Hg19::chr12:92401823..92401837,+	p@chr12:92401823..92401837 +
Hg19::chr12:92401866..92401875,+	p@chr12:92401866..92401875 +
Hg19::chr13:26619917..26619921,-	p@chr13:26619917..26619921 -
Hg19::chr13:26626147..26626161,-	p@chr13:26626147..26626161 -
Hg19::chr13:33498605..33498607,-	p@chr13:33498605..33498607 -
Hg19::chr13:38508582..38508616,+	p2@CR627261
Hg19::chr13:93329950..93329974,-	p@chr13:93329950..93329974 -
Hg19::chr13:93372213..93372253,-	p1@GPC5-AS1
Hg19::chr13:93372254..93372268,-	p2@GPC5-AS1
Hg19::chr13:93372269..93372274,-	p3@GPC5-AS1
Hg19::chr13:93372283..93372290,-	p4@GPC5-AS1
Hg19::chr13:93439916..93439921,-	p@chr13:93439916..93439921 -
Hg19::chr13:93508642..93508652,-	p@chr13:93508642..93508652 -
Hg19::chr14:105637918..105637925,-	p@chr14:105637918..105637925 -
Hg19::chr14:105643341..105643359,-	p@chr14:105643341..105643359 -
Hg19::chr14:76278486..76278493,+	p@chr14:76278486..76278493 +
Hg19::chr14:76447825..76447863,-	p5@TGFB3
Hg19::chr15:51981498..51981513,+	p@chr15:51981498..51981513 +
Hg19::chr15:51984388..51984400,+	p6@SCG3
Hg19::chr15:59908653..59908680,+	p4@GCNT3
Hg19::chr15:74528745..74528750,+	p8@CCDC33
Hg19::chr15:74612015..74612053,-	p@chr15:74612015..74612053 -
Hg19::chr16:1132642..1132649,-	p@chr16:1132642..1132649 -
Hg19::chr16:1205163..1205193,+	p@chr16:1205163..1205193 +
Hg19::chr16:12121188..12121212,+	p@chr16:12121188..12121212 +
Hg19::chr16:15670786..15670791,-	p@chr16:15670786..15670791 -
Hg19::chr16:15672837..15672851,+	p@chr16:15672837..15672851 +
Hg19::chr16:15699973..15700008,-	p10@KIAA0430
Hg19::chr16:1631093..1631103,-	p@chr16:1631093..1631103 -
Hg19::chr16:1968408..1968425,-	p1@HS3ST6
Hg19::chr16:23313614..23313629,+	p2@SCNN1B
Hg19::chr16:23313645..23313671,+	p1@SCNN1B
Hg19::chr16:71378536..71378548,-	p@chr16:71378536..71378548 -
Hg19::chr16:735116..735143,-	p@chr16:735116..735143 -
Hg19::chr17:1666131..1666142,+	p@chr17:1666131..1666142 +
Hg19::chr18:56815532..56815544,+	p@chr18:56815532..56815544 +
Hg19::chr18:56816249..56816258,+	p@chr18:56816249..56816258 +
Hg19::chr18:56816267..56816276,+	p@chr18:56816267..56816276 +
Hg19::chr18:56816796..56816816,+	p@chr18:56816796..56816816 +
Hg19::chr18:56819783..56819803,+	p@chr18:56819783..56819803 +
Hg19::chr18:56822974..56823004,-	p@chr18:56822974..56823004 -
Hg19::chr18:71843121..71843138,+	p@chr18:71843121..71843138 +
Hg19::chr18:71843159..71843180,+	p@chr18:71843159..71843180 +
Hg19::chr18:904938..904986,+	p2@ADCYAP1
Hg19::chr18:904994..905011,+	p5@ADCYAP1
Hg19::chr18:905092..905103,+	p12@ADCYAP1
Hg19::chr18:905104..905118,+	p10@ADCYAP1
Hg19::chr19:10823418..10823430,+	p15@DNM2
Hg19::chr19:10823451..10823463,+	p10@DNM2
Hg19::chr19:10823464..10823473,+	p16@DNM2
Hg19::chr19:3068219..3068225,-	p@chr19:3068219..3068225 -
Hg19::chr19:42638173..42638181,+	p1@ENST00000531517
Hg19::chr19:51537964..51537973,-	p6@KLK12
Hg19::chr19:51537982..51537991,-	p8@KLK12
Hg19::chr19:51538017..51538048,-	p3@KLK12
Hg19::chr19:51538096..51538109,-	p5@KLK12
Hg19::chr19:51538121..51538134,-	p4@KLK12
Hg19::chr1:147084502..147084507,+	p@chr1:147084502..147084507 +
Hg19::chr1:15416193..15416195,-	p@chr1:15416193..15416195 -
Hg19::chr1:165198157..165198181,-	p@chr1:165198157..165198181 -
Hg19::chr1:17906670..17906682,+	p17@ARHGEF10L
Hg19::chr1:18807428..18807451,+	p2@KLHDC7A
Hg19::chr1:188791401..188791408,-	p@chr1:188791401..188791408 -
Hg19::chr1:209237425..209237437,-	p@chr1:209237425..209237437 -
Hg19::chr1:222763113..222763144,-	p3@TAF1A
Hg19::chr1:222763161..222763178,-	p4@TAF1A
Hg19::chr1:223853355..223853378,-	p2@CAPN8
Hg19::chr1:223853388..223853408,-	p1@CAPN8
Hg19::chr1:223853431..223853436,-	p4@CAPN8
Hg19::chr1:226067570..226067582,-	p@chr1:226067570..226067582 -
Hg19::chr1:27240361..27240377,-	p2@NR0B2
Hg19::chr1:39749767..39749791,+	p17@MACF1
Hg19::chr1:52442908..52442917,-	p9@RAB3B
Hg19::chr1:55446384..55446413,+	p3@TMEM61
Hg19::chr20:10996541..10996543,+	p@chr20:10996541..10996543 +
Hg19::chr20:17207711..17207722,+	p3@PCSK2
Hg19::chr20:2310990..2310996,+	p@chr20:2310990..2310996 +
Hg19::chr20:2311002..2311015,+	p@chr20:2311002..2311015 +
Hg19::chr20:3184528..3184549,-	p@chr20:3184528..3184549 -
Hg19::chr20:3184707..3184740,+	p@chr20:3184707..3184740 +
Hg19::chr20:31958369..31958376,-	p@chr20:31958369..31958376 -
Hg19::chr20:31958409..31958418,-	p@chr20:31958409..31958418 -
Hg19::chr20:33114038..33114096,+	p2@DYNLRB1
Hg19::chr20:3780693..3780714,+	p17@CDC25B
Hg19::chr20:49241036..49241049,-	p@chr20:49241036..49241049 -
Hg19::chr20:5896962..5896986,+	p@chr20:5896962..5896986 +
Hg19::chr22:24251729..24251732,-	p@chr22:24251729..24251732 -
Hg19::chr22:25297679..25297722,+	p@chr22:25297679..25297722 +
Hg19::chr2:135011636..135011649,+	p8@MGAT5
Hg19::chr2:163942394..163942398,+	p@chr2:163942394..163942398 +
Hg19::chr2:170367210..170367234,+	p6@KBTBD10
Hg19::chr2:191221240..191221253,+	p17@INPP1
Hg19::chr2:214788522..214788538,+	p2@SPAG16
Hg19::chr2:236414196..236414199,+	p1@AGAP1-IT1
Hg19::chr2:2617159..2617172,-	p@chr2:2617159..2617172 -
Hg19::chr2:99758223..99758246,+	p3@C2orf15 p6@MRPL30
Hg19::chr3:129813701..129813712,+	p@chr3:129813701..129813712 +
Hg19::chr3:13369325..13369334,-	p6@NUP210
Hg19::chr3:148994474..148994479,-	p1@CPHL1P
Hg19::chr3:176474114..176474132,-	p@chr3:176474114..176474132 -
Hg19::chr3:186713943..186713982,+	p35@ST6GAL1
Hg19::chr3:20038294..20038297,+	p1@ENST00000364675
Hg19::chr3:55328211..55328214,+	p@chr3:55328211..55328214 +
Hg19::chr3:55361260..55361286,-	p@chr3:55361260..55361286 -
Hg19::chr4:10736435..10736454,-	p@chr4:10736435..10736454 -
Hg19::chr4:10736455..10736475,-	p@chr4:10736455..10736475 -
Hg19::chr4:10736487..10736498,-	p@chr4:10736487..10736498 -
Hg19::chr4:114880636..114880650,+	p@chr4:114880636..114880650 +
Hg19::chr4:116034768..116034781,-	p2@NDST4
Hg19::chr4:144354723..144354734,+	p@chr4:144354723..144354734 +
Hg19::chr4:156364770..156364801,+	p@chr4:156364770..156364801 +
Hg19::chr5:102143765..102143784,+	p22@PAM
Hg19::chr5:102143805..102143822,+	p13@PAM
Hg19::chr5:102143830..102143844,+	p18@PAM
Hg19::chr5:102143863..102143874,+	p23@PAM
Hg19::chr5:125800836..125800850,+	p21@GRAMD3
Hg19::chr5:138429594..138429616,-	p7@SIL1
Hg19::chr5:15902227..15902252,-	p@chr5:15902227..15902252 -
Hg19::chr5:40415240..40415245,+	p@chr5:40415240..40415245 +
Hg19::chr5:54157..54174,+	p@chr5:54157..54174 +
Hg19::chr6:132980317..132980326,-	p@chr6:132980317..132980326 -
Hg19::chr6:132980338..132980346,-	p@chr6:132980338..132980346 -
Hg19::chr6:24980950..24980956,+	p@chr6:24980950..24980956 +
Hg19::chr6:32134832..32134862,+	p11@EGFL8
Hg19::chr6:41168871..41168911,-	p1@TREML2
Hg19::chr6:41168920..41168927,-	p4@TREML2
Hg19::chr6:48219854..48219891,-	p@chr6:48219854..48219891 -
Hg19::chr6:49695621..49695625,-	p@chr6:49695621..49695625 -
Hg19::chr6:49696401..49696408,-	p@chr6:49696401..49696408 -
Hg19::chr6:49701451..49701462,-	p@chr6:49701451..49701462 -
Hg19::chr6:49712072..49712087,-	p2@CRISP3
Hg19::chr7:100816687..100816697,-	p4@NAT16
Hg19::chr7:130600779..130600797,+	p@chr7:130600779..130600797 +
Hg19::chr7:130600802..130600814,+	p@chr7:130600802..130600814 +
Hg19::chr7:150499243..150499249,-	p@chr7:150499243..150499249 -
Hg19::chr7:150499392..150499424,-	p@chr7:150499392..150499424 -
Hg19::chr7:150499428..150499436,-	p@chr7:150499428..150499436 -
Hg19::chr7:150499437..150499449,-	p@chr7:150499437..150499449 -
Hg19::chr7:150500070..150500081,+	p27@TMEM176A
Hg19::chr7:150500286..150500288,-	p@chr7:150500286..150500288 -
Hg19::chr7:150500382..150500396,+	p9@TMEM176A
Hg19::chr7:150500441..150500448,+	p34@TMEM176A
Hg19::chr7:150675342..150675363,-	p4@KCNH2
Hg19::chr7:150675372..150675417,-	p1@KCNH2
Hg19::chr7:21985656..21985667,-	p3@CDCA7L
Hg19::chr7:26415673..26415697,-	p@chr7:26415673..26415697 -
Hg19::chr7:26578438..26578451,-	p2@KIAA0087
Hg19::chr7:26578466..26578485,-	p1@KIAA0087
Hg19::chr7:27191798..27191816,-	p@chr7:27191798..27191816 -
Hg19::chr7:29971838..29971870,-	p@chr7:29971838..29971870 -
Hg19::chr7:36327304..36327316,+	p11@EEPD1
Hg19::chr7:36327318..36327333,+	p14@EEPD1
Hg19::chr7:872107..872145,+	p2@SUN1
Hg19::chr7:92300854..92300857,-	p@chr7:92300854..92300857 -
Hg19::chr7:92300908..92300913,-	p@chr7:92300908..92300913 -
Hg19::chr7:99541928..99541935,-	p@chr7:99541928..99541935 -
Hg19::chr8:10122760..10122784,+	p@chr8:10122760..10122784 +
Hg19::chr8:104148509..104148517,+	p@chr8:104148509..104148517 +
Hg19::chr8:125183765..125183776,-	p1@ENST00000520031 p1@uc003yqy.1
Hg19::chr8:139856402..139856426,-	p@chr8:139856402..139856426 -
Hg19::chr8:141018634..141018657,-	p6@TRAPPC9
Hg19::chr8:141018664..141018674,-	p15@TRAPPC9
Hg19::chr8:2104622..2104638,+	p2@ENST00000518316
Hg19::chr8:29592736..29592744,-	p3@C8orf75
Hg19::chr9:130738884..130738902,-	p@chr9:130738884..130738902 -
Hg19::chr9:130738905..130738929,-	p@chr9:130738905..130738929 -
Hg19::chr9:133816046..133816048,-	p@chr9:133816046..133816048 -
Hg19::chr9:133816054..133816060,-	p@chr9:133816054..133816060 -
Hg19::chr9:133816065..133816079,-	p@chr9:133816065..133816079 -
Hg19::chr9:133816081..133816105,-	p@chr9:133816081..133816105 -
Hg19::chr9:136467523..136467541,-	p@chr9:136467523..136467541 -
Hg19::chr9:136499577..136499584,+	p@chr9:136499577..136499584 +
Hg19::chr9:136753424..136753441,-	p@chr9:136753424..136753441 -
Hg19::chr9:139940990..139941047,-	p4@NPDC1
Hg19::chrX:103810874..103810885,+	p1@IL1RAPL2
Hg19::chrX:104100378..104100381,+	p@chrX:104100378..104100381 +

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0005737	cytoplasm	0.00283719973544866
GO:0030141	secretory granule	0.00283719973544866
GO:0007189	G-protein signaling, adenylate cyclase activating pathway	0.00283719973544866
GO:0044444	cytoplasmic part	0.00921918044552319
GO:0000139	Golgi membrane	0.00921918044552319
GO:0000267	cell fraction	0.00921918044552319
GO:0005179	hormone activity	0.00921918044552319
GO:0007188	G-protein signaling, coupled to cAMP nucleotide second messenger	0.00921918044552319
GO:0044431	Golgi apparatus part	0.00921918044552319
GO:0019933	cAMP-mediated signaling	0.00921918044552319
GO:0031410	cytoplasmic vesicle	0.00921918044552319
GO:0031982	vesicle	0.00921918044552319
GO:0005625	soluble fraction	0.00921918044552319
GO:0005794	Golgi apparatus	0.00921918044552319
GO:0007190	adenylate cyclase activation	0.0145487135589096
GO:0045087	innate immune response	0.0145487135589096
GO:0007187	G-protein signaling, coupled to cyclic nucleotide second messenger	0.0145487135589096
GO:0019935	cyclic-nucleotide-mediated signaling	0.0145487135589096
GO:0051349	positive regulation of lyase activity	0.0145487135589096
GO:0045762	positive regulation of adenylate cyclase activity	0.0145487135589096
GO:0031281	positive regulation of cyclase activity	0.0145487135589096
GO:0005184	neuropeptide hormone activity	0.0194955752777347
GO:0022402	cell cycle process	0.0194955752777347
GO:0008015	blood circulation	0.0194955752777347
GO:0003013	circulatory system process	0.0194955752777347
GO:0006936	muscle contraction	0.0194955752777347
GO:0003012	muscle system process	0.0194955752777347
GO:0045761	regulation of adenylate cyclase activity	0.0194955752777347
GO:0042581	specific granule	0.0194955752777347
GO:0004441	inositol-1,4-bisphosphate 1-phosphatase activity	0.0194955752777347
GO:0048702	embryonic neurocranium morphogenesis	0.0194955752777347
GO:0004598	peptidylamidoglycolate lyase activity	0.0194955752777347
GO:0031716	calcitonin receptor binding	0.0194955752777347
GO:0004286	proprotein convertase 2 activity	0.0194955752777347
GO:0001984	vasodilation of artery during baroreceptor response to increased systemic arterial blood pressure	0.0194955752777347
GO:0042271	susceptibility to natural killer cell mediated cytotoxicity	0.0194955752777347
GO:0035150	regulation of tube size	0.0194955752777347
GO:0050880	regulation of blood vessel size	0.0194955752777347
GO:0051339	regulation of lyase activity	0.0194955752777347
GO:0031279	regulation of cyclase activity	0.0194955752777347
GO:0008016	regulation of heart contraction	0.0194955752777347
GO:0003018	vascular process in circulatory system	0.0195443769341191
GO:0006486	protein amino acid glycosylation	0.0195443769341191
GO:0043413	biopolymer glycosylation	0.0200595991583854
GO:0008375	acetylglucosaminyltransferase activity	0.0200900194078242
GO:0007154	cell communication	0.0200900194078242
GO:0009101	glycoprotein biosynthetic process	0.0200900194078242
GO:0003015	heart process	0.0200900194078242
GO:0060047	heart contraction	0.0200900194078242
GO:0012505	endomembrane system	0.0200900194078242
GO:0005102	receptor binding	0.0205864393041321
GO:0008146	sulfotransferase activity	0.0234886471417827
GO:0007165	signal transduction	0.0248165823120294
GO:0009100	glycoprotein metabolic process	0.0248165823120294
GO:0051649	establishment of cellular localization	0.0248165823120294
GO:0043229	intracellular organelle	0.0248165823120294
GO:0043226	organelle	0.0248165823120294
GO:0006948	induction by virus of cell-cell fusion in host	0.0248165823120294
GO:0004910	interleukin-1, Type II, blocking receptor activity	0.0248165823120294
GO:0001983	baroreceptor response to increased systemic arterial blood pressure	0.0248165823120294
GO:0019968	interleukin-1, Type II, blocking binding	0.0248165823120294
GO:0016312	inositol bisphosphate phosphatase activity	0.0248165823120294
GO:0030144	alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase activity	0.0248165823120294
GO:0051641	cellular localization	0.0248165823120294
GO:0048523	negative regulation of cellular process	0.025477497950714
GO:0031420	alkali metal ion binding	0.025477497950714
GO:0016782	transferase activity, transferring sulfur-containing groups	0.0256829987908073
GO:0045786	negative regulation of progression through cell cycle	0.0256829987908073
GO:0048519	negative regulation of biological process	0.0292832235172398
GO:0065002	intracellular protein transport across a membrane	0.0301046166136714
GO:0007049	cell cycle	0.0301046166136714
GO:0035313	wound healing, spreading of epidermal cells	0.0301046166136714
GO:0004504	peptidylglycine monooxygenase activity	0.0301046166136714
GO:0003829	beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity	0.0301046166136714
GO:0016808	proprotein convertase activity	0.0301046166136714
GO:0050961	detection of temperature stimulus during sensory perception	0.0301046166136714
GO:0050965	detection of temperature stimulus during sensory perception of pain	0.0301046166136714
GO:0045932	negative regulation of muscle contraction	0.0301046166136714
GO:0045986	negative regulation of smooth muscle contraction	0.0301046166136714
GO:0043085	positive regulation of catalytic activity	0.0309776874453533
GO:0043065	positive regulation of apoptosis	0.0309776874453533
GO:0043068	positive regulation of programmed cell death	0.031272145987102
GO:0051606	detection of stimulus	0.0320111792065642
GO:0019932	second-messenger-mediated signaling	0.0320111792065642
GO:0035239	tube morphogenesis	0.0320111792065642
GO:0002028	regulation of sodium ion transport	0.0320111792065642
GO:0043195	terminal button	0.0320111792065642
GO:0033267	axon part	0.0320111792065642
GO:0016048	detection of temperature stimulus	0.0320111792065642
GO:0050951	sensory perception of temperature stimulus	0.0320111792065642
GO:0048701	embryonic cranial skeleton morphogenesis	0.0320111792065642
GO:0003835	beta-galactoside alpha-2,6-sialyltransferase activity	0.0320111792065642
GO:0007184	SMAD protein nuclear translocation	0.0320111792065642
GO:0008109	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity	0.0320111792065642
GO:0003701	RNA polymerase I transcription factor activity	0.0320111792065642
GO:0001978	carotid sinus baroreceptor feedback regulation of systemic arterial blood pressure	0.0320111792065642
GO:0003025	baroreceptor regulation of systemic arterial blood pressure	0.0320111792065642
GO:0031403	lithium ion binding	0.0320111792065642
GO:0015016	[heparan sulfate]-glucosamine N-sulfotransferase activity	0.0320111792065642
GO:0016021	integral to membrane	0.0327749287978127
GO:0045184	establishment of protein localization	0.0342165106167176
GO:0031224	intrinsic to membrane	0.0342165106167176
GO:0044464	cell part	0.0347920793349787
GO:0006952	defense response	0.035617442548693
GO:0008467	heparin-glucosamine 3-O-sulfotransferase activity	0.0369999458837642
GO:0048265	response to pain	0.0369999458837642
GO:0003085	negative regulation of systemic arterial blood pressure	0.0369999458837642
GO:0008104	protein localization	0.038105327651986
GO:0042995	cell projection	0.0401647866387421
GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	0.0412863325297617
GO:0002027	regulation of heart rate	0.0412863325297617
GO:0001912	positive regulation of leukocyte mediated cytotoxicity	0.0412863325297617
GO:0051482	elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)	0.0412863325297617
GO:0045954	positive regulation of natural killer cell mediated cytotoxicity	0.0412863325297617
GO:0045778	positive regulation of ossification	0.0412863325297617
GO:0005856	cytoskeleton	0.0418085846115234
GO:0050794	regulation of cellular process	0.0424296841742674
GO:0007267	cell-cell signaling	0.042790728048361
GO:0033036	macromolecule localization	0.042790728048361
GO:0051049	regulation of transport	0.04398091260169
GO:0042269	regulation of natural killer cell mediated cytotoxicity	0.0446444351479221
GO:0031645	negative regulation of neurological process	0.0446444351479221
GO:0005868	cytoplasmic dynein complex	0.0446444351479221
GO:0046852	positive regulation of bone remodeling	0.0446444351479221
GO:0016023	cytoplasmic membrane-bound vesicle	0.046404432021233
GO:0035295	tube development	0.0471555423947684
GO:0031988	membrane-bound vesicle	0.0473811370175228
GO:0000074	regulation of progression through cell cycle	0.0473811370175228
GO:0048518	positive regulation of biological process	0.0473811370175228
GO:0045776	negative regulation of blood pressure	0.0473811370175228
GO:0004908	interleukin-1 receptor activity	0.0473811370175228
GO:0030279	negative regulation of ossification	0.0473811370175228
GO:0001976	regulation of systemic arterial blood pressure by neurological process	0.0473811370175228
GO:0051726	regulation of cell cycle	0.0473811370175228
GO:0005515	protein binding	0.0473811370175228
GO:0031090	organelle membrane	0.048147535383269
GO:0044425	membrane part	0.0491408776240159

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>

---

Uber Anatomy

Ontology term	p-value	n
adult organism	1.00e-41	115
neural tube	8.74e-23	57
neural rod	8.74e-23	57
future spinal cord	8.74e-23	57
neural keel	8.74e-23	57
central nervous system	2.08e-22	82
regional part of nervous system	1.42e-21	94
nervous system	1.42e-21	94
regional part of brain	9.23e-19	59
brain	2.09e-18	69
future brain	2.09e-18	69
neurectoderm	7.92e-18	90
anterior neural tube	1.13e-17	42
neural plate	1.69e-17	86
presumptive neural plate	1.69e-17	86
regional part of forebrain	2.25e-17	41
forebrain	2.25e-17	41
future forebrain	2.25e-17	41
ectoderm	8.38e-15	173
presumptive ectoderm	8.38e-15	173
ectoderm-derived structure	2.27e-14	169
gray matter	3.45e-14	34
brain grey matter	3.45e-14	34
telencephalon	6.45e-14	34
regional part of telencephalon	1.72e-13	33
cerebral hemisphere	2.17e-13	32
pre-chordal neural plate	1.71e-12	61
anterior region of body	1.95e-12	129
craniocervical region	1.95e-12	129
head	1.72e-11	123
regional part of cerebral cortex	4.67e-11	22
cerebral cortex	1.01e-10	25
pallium	1.01e-10	25
neocortex	2.54e-10	20
organ part	7.90e-09	219
subdivision of digestive tract	8.14e-09	129
endodermal part of digestive tract	8.14e-09	129
multi-tissue structure	7.14e-08	347
gastrointestinal system	1.70e-07	35
digestive system	3.99e-07	155
digestive tract	3.99e-07	155
primitive gut	3.99e-07	155

Disease

Ontology term	p-value	n
carcinoma	4.00e-13	106
cell type cancer	1.18e-12	143
cancer	3.97e-07	235
disease of cellular proliferation	6.90e-07	239
adenocarcinoma	8.09e-07	25

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF	#promoters	Enrichment	p-value	q-value
FOXA1#3169	29	1.62303622592009	0.00657924540417041	0.0281126671616952
SUZ12#23512	10	2.53110004601328	0.00685254677668615	0.0290416399306223

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---